Both injectable semaglutide and oral semaglutide can cause similar side effects
In cell models such as ECs exposed to hypoxia or high glucose, L-citrulline supplementation restores NO bioavailability and reduces ARG2 expression level and activity (Douglass et al., 2023
If you have established cardiovascular disease and meet criteria, note that semaglutide has evidence for cardiovascular risk reduction in people with overweight/obesity without diabetes
Our skilled team prioritizes both safety and comfort, so most people feel little to no discomfort
Despite these severe risks, many manufacturers failed to provide adequate warnings, leaving patients unaware of the potential dangers they were facing
Facchinetti F, Espinola MSB, Dewailly D, et al